Advisornet Financial’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.2K | Sell |
142
-25
| -15% | -$2.19K | ﹤0.01% | 1527 |
|
|
2026
Q1 | $15.1K | Sell |
167
-31
| -16% | -$2.85K | ﹤0.01% | 1414 |
|
|
2025
Q4 | $17.8K | Buy |
198
+38
| +24% | +$3.6K | ﹤0.01% | 1375 |
|
|
2025
Q3 | $15.8K | Sell |
160
-31
| -16% | -$3.07K | ﹤0.01% | 1381 |
|
|
2025
Q2 | $17.4K | Buy |
191
+1
| +0.5% | +$97 | ﹤0.01% | 1321 |
|
|
2025
Q1 | $21.5K | Sell |
190
-55
| -22% | -$5.88K | ﹤0.01% | 1165 |
|
|
2024
Q4 | $25.9K | Sell |
245
-190
| -44% | -$20.4K | ﹤0.01% | 1058 |
|
|
2024
Q3 | $47K | Buy |
435
+120
| +38% | +$13.1K | ﹤0.01% | 923 |
|
|
2024
Q2 | $34.2K | Sell |
315
-10
| -3% | -$1.18K | ﹤0.01% | 939 |
|
|
2024
Q1 | $42.9K | Sell |
325
-10
| -3% | -$1.25K | ﹤0.01% | 853 |
|
|
2023
Q4 | $40.8K | Buy |
335
+28
| +9% | +$3.12K | ﹤0.01% | 863 |
|
|
2023
Q3 | $34.5K | Sell |
307
-25
| -8% | -$3.17K | ﹤0.01% | 881 |
|
|
2023
Q2 | $48.3K | Buy |
332
+8
| +2% | +$1.09K | ﹤0.01% | 823 |
|
|
2023
Q1 | $41.9K | Buy |
324
+3
| +0.9% | +$377 | ﹤0.01% | 839 |
|
|
2022
Q4 | $40.9K | Sell |
321
-86
| -21% | -$9.98K | ﹤0.01% | 848 |
|
|
2022
Q3 | $43K | Buy |
407
+55
| +16% | +$6.04K | ﹤0.01% | 896 |
|
|
2022
Q2 | $37K | Sell |
352
-110
| -24% | -$13.1K | ﹤0.01% | 967 |
|
|
2022
Q1 | $59K | Sell |
462
-59
| -11% | -$7.11K | ﹤0.01% | 913 |
|
|
2021
Q4 | $64K | Buy |
521
+39
| +8% | +$5.1K | ﹤0.01% | 934 |
|
|
2021
Q3 | $69K | Hold |
482
| – | – | ﹤0.01% | 909 |
|
|
2021
Q2 | $75K | Hold |
482
| – | – | 0.01% | 866 |
|
|
2021
Q1 | $75K | Hold |
482
| – | – | 0.01% | 836 |
|
|
2020
Q4 | $72K | Hold |
482
| – | – | 0.01% | 783 |
|
|
2020
Q3 | $64K | Hold |
482
| – | – | 0.01% | 797 |
|
|
2020
Q2 | $56K | Hold |
482
| – | – | ﹤0.01% | 827 |
|
|
2020
Q1 | $47K | Buy |
482
+62
| +15% | +$8.13K | ﹤0.01% | 818 |
|
|
2019
Q4 | $61K | Buy |
420
+101
| +32% | +$13.9K | 0.01% | 836 |
|
|
2019
Q3 | $43K | Hold |
319
| – | – | ﹤0.01% | 960 |
|
|
2019
Q2 | $36K | Sell |
319
-42
| -12% | -$4.92K | ﹤0.01% | 910 |
|
|
2019
Q1 | $45K | Hold |
361
| – | – | 0.01% | 766 |
|
|
2018
Q4 | $36K | Hold |
361
| – | – | 0.01% | 770 |
|
|
2018
Q3 | $46K | Hold |
361
| – | – | 0.01% | 753 |
|
|
2018
Q2 | $39K | Sell |
361
-13
| -3% | -$1.42K | 0.01% | 781 |
|
|
2018
Q1 | $40K | Buy |
374
+13
| +4% | +$1.51K | 0.01% | 753 |
|
|
2017
Q4 | $42K | Buy |
+361
| New | +$40.8K | 0.01% | 691 |
|
Other funds holding ZBH
Advisornet Financial's ZBH Position: Q2 2026 in Review
Advisornet Financial reduced its Zimmer Biomet (ZBH) stake by 15% in Q2 2026, selling an estimated $2.19K and leaving 142 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1527.
Advisornet Financial first reported a position in ZBH in Q4 2017 and has held it in 35 quarters since. The position peaked at $75K in Q2 2021. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Advisornet Financial held 142 shares of Zimmer Biomet worth $12.2K as of Q2 2026.
- Advisornet Financial sold 25 Zimmer Biomet shares in Q2 2026, an estimated $2.19K.
- Zimmer Biomet made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1527 holding.
- Advisornet Financial first reported a position in Zimmer Biomet in Q4 2017 and has held it in 35 quarters since.
- Advisornet Financial's Zimmer Biomet position peaked at $75K in Q2 2021.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.